What Is the Endometriosis Surgery Success Rate?

Learn how surgical technique, post-op care, and patient goals determine the true success rate of endometriosis treatment.

Endometriosis surgery relieves pain for roughly two-thirds of patients over the long term, but that single number hides enormous variation depending on what you mean by “success,” which surgical technique is used, how deeply the disease has spread, and whether hormonal therapy follows the procedure. A study tracking patients after laparoscopic excision found that about two-thirds remained pain-free years later, while the remaining third experienced pain recurrence after an average of roughly two years. The reality is that “success rate” in endometriosis surgery is not one number but a constellation of outcomes, and the answer shifts depending on what matters most to you.

What Counts as Success

One of the reasons the success rate question is so hard to pin down is that researchers themselves measure it differently. Some studies define success as being pain-free at a specific follow-up point. Others look at whether the disease visually recurs on imaging or at a second surgery. Still others prioritize pregnancy rates, quality-of-life scores, or the need for repeat operations. One research framework judged a therapy “most successful” only if it met at least two of three criteria: a high rate of clearing visible disease, a low recurrence rate, and a high pregnancy rate. This lack of a single agreed-upon definition is why you will see wildly different percentages quoted online, and why the number you encounter depends heavily on which outcome the study happened to track.

Quality-of-life measures offer a more holistic picture. Research using the Endometriosis Health Profile-30, a validated questionnaire covering pain, emotional well-being, social support, self-image, and work life, consistently shows significant improvements across every domain after laparoscopic surgery. In one study, those improvements appeared within four weeks and persisted for nearly seven years of follow-up. A separate study confirmed significant reductions in scores related to pain, feelings of powerlessness, sexual function, and concerns about infertility after laparoscopic surgery. So even when pain is not completely eliminated, surgery often meaningfully improves how people experience daily life.

Excision Versus Ablation

The two main laparoscopic techniques for treating endometriosis lesions are excision, which cuts out the tissue, and ablation, which destroys it on the surface using heat or laser energy. Excision is generally considered the more thorough approach, and a meta-analysis found that it produced significantly greater improvements in period pain, painful bowel movements, and chronic pelvic pain compared with ablation at twelve months after surgery.

The picture is less clear-cut for superficial disease. A randomized trial comparing excision and ablation specifically for superficial endometriosis found that both techniques produced similar overall effectiveness, and ablation actually showed more significant individual improvements in period pain at six and twelve months. This suggests that for lesions that sit only on the peritoneal surface, ablation can be a reasonable option. For deeper disease, excision appears to have the edge, particularly for bowel-related symptoms and overall pelvic pain. The practical takeaway: the technique matters less for shallow lesions and matters more for anything that penetrates deeper into tissue.

How Often Does Endometriosis Come Back

Recurrence is one of the most frustrating aspects of endometriosis surgery. Published recurrence rates range enormously, from as low as about 6% to as high as 67%, depending on the criteria used and the length of follow-up. That spread is wide enough to be almost meaningless on its own, so it helps to look at more specific data.

A large study following patients after laparoscopic surgery for deep infiltrating endometriosis found a cumulative recurrence rate of about 7% at six years, climbing to roughly 14% by twelve years. Pain recurrence in that cohort was particularly low at just over 1%. A retrospective study of moderate and severe endometriosis reported a recurrence rate of about 22%, with younger age (under 35) being a significant risk factor. One large study that tracked over 700 women after conservative surgery found a cumulative disease relapse rate of about 12% at three years, though higher-stage disease (stage IV) had a relapse rate closer to 23%.

The general pattern: the more thorough the initial surgery and the longer you use post-operative medical therapy, the lower the recurrence rate tends to be. But recurrence is never zero, and the longer you follow someone, the more it creeps upward. Surgery manages endometriosis; it rarely cures it permanently.

Fertility After Surgery

For people trying to conceive, the fertility picture after endometriosis surgery is generally encouraging but comes with important caveats. In mild to moderate disease, excision or ablation of peritoneal endometriosis has been shown to increase pregnancy rates. In severe endometriosis, controlled trials also suggest improved pregnancy rates after surgery. A study of women with deep infiltrating endometriosis involving the bowel found pregnancy rates between 23% and 57%, with a cumulative rate of 58% to 70% within four years. In one smaller study, about 80% of previously infertile patients who attempted to conceive after excision surgery were successful.

A critical finding, though, is that first surgeries produce much better fertility outcomes than repeat operations. A meta-analysis found that the odds of spontaneous pregnancy were roughly twice as high after a primary surgery compared with a reoperation, and pregnancy rates with assisted reproduction were about two and a half times higher after a first operation. The same review that looked at primary surgery’s advantages also noted that for patients who had already failed an initial surgery, assisted reproduction was significantly more effective than going back for a second operation. This has real implications for planning: if fertility is your primary goal, the first surgery matters most, and repeating surgery tends to yield diminishing returns.

The Ovarian Reserve Trade-Off

Endometriomas, the cyst-like growths that form on the ovaries, present a particular dilemma. Removing them through cystectomy (the standard stripping technique) does improve pregnancy rates and reduce recurrence, but it comes at a measurable cost to ovarian reserve. A meta-analysis found a significant drop in anti-Müllerian hormone (AMH), a key marker of remaining egg supply, after ovarian cystectomy. A more recent umbrella review confirmed this finding and quantified it more precisely: the damage to ovarian reserve was more severe in bilateral cases (both ovaries) than unilateral cases, and repeat cystectomy was especially harmful.

Some evidence suggests that alternative approaches, like ablating the inner cyst wall with plasma energy instead of stripping it out, may cause less damage to the ovary while offering similar recurrence rates. If you are planning to conceive in the near future or considering egg freezing, this trade-off is worth a direct conversation with your surgeon before the procedure, not after.

Deep Infiltrating Endometriosis

Deep infiltrating endometriosis, where lesions grow more than five millimeters below the peritoneal surface and can invade the bowel, bladder, or ureters, is the most surgically complex form of the disease. The overall recurrence rate in studies with more than two years of follow-up has been reported at 5% to 25%, with most studies landing around 10%. Pain improvement is reported in most studies, though the quality of pain assessment varies widely.

The complication profile is more serious than for superficial disease. Bowel surgery, when required, carries a higher risk of severe complications. One study comparing three bowel surgery techniques found that segmental resection (removing a section of bowel) had a severe complication rate of about 24%, including fistulas, fecal incontinence, and anastomotic leakage, compared with 5% for disc resection and near zero for shaving. This is why multidisciplinary teams, typically involving a gynecologist, colorectal surgeon, and urologist, are considered essential for these operations. One study found that after centralizing complex endometriosis care in a multidisciplinary setting, complex surgeries were more often planned as a team effort and there was a modest reduction in complication risk.

Why Your Surgeon’s Experience Matters

This is one of the most underappreciated factors in endometriosis surgery outcomes. A study examining the impact of surgeon characteristics found that patients who had their procedure performed by a high-volume complex endometriosis surgeon were significantly less likely to need repeat surgery: about 18% versus 33% for patients treated by lower-volume surgeons. That difference is substantial. A separate study found that patients with more advanced disease (rAFS scores above 70) had about a 36% chance of needing further surgery after excision. Surgeon experience interacts with disease severity: the harder the case, the more the surgeon’s skill level influences the outcome.

MRI-based pre-surgical mapping has also become an increasingly important part of the process. A dedicated MRI protocol with structured reporting helps the surgical team understand the extent of disease before the operation, plan for which specialists need to be in the operating room, and counsel the patient on what to expect. A well-mapped surgery is a better surgery.

Hormonal Therapy After Surgery

What happens after the surgery can be just as important as the surgery itself. A systematic review and meta-analysis found that post-operative hormonal suppression cut the risk of endometriosis recurrence by about 59% compared to no treatment, and patients who received it also had significantly lower pain scores. The benefit held across subgroup analyses of combined hormonal contraceptives and levonorgestrel-releasing intrauterine systems.

There is an important distinction between short-course and long-term therapy. A short course of three to six months of hormonal treatment after surgery has shown limited benefit for endometriosis overall. The stronger evidence supports prolonged hormonal therapy, which appears more effective at preventing endometrioma recurrence and period-pain relapse. A network meta-analysis comparing different maintenance medications found that several options significantly reduced endometrioma recurrence compared to no treatment, with combination regimens and progestins ranking highest. If you are not immediately trying to conceive, long-term hormonal suppression after surgery is one of the strongest tools for keeping the disease at bay.

When Surgery Does Not Fix the Pain

About a third of patients in long-term studies report that pain returns after surgery, and a subset never gets adequate relief despite technically successful operations. One reason for this is central sensitization, a phenomenon where the nervous system itself becomes hypersensitive after years of pain input, so that pain persists even after the physical source has been removed. Research has found that patients with higher scores on a central sensitization questionnaire before surgery were significantly more likely to report persistent pelvic pain, deep pain during sex, and back pain after surgery, even after accounting for their baseline pain levels. A systematic review confirmed that patients meeting clinical criteria for central sensitization syndromes had a significantly increased incidence of persistent pain after surgical treatment.

This does not mean surgery was pointless for these patients. It means that the disease and the pain have partially decoupled: the endometriosis needed removal, but the nervous system also needs separate treatment. A multimodal protocol combining trigger point injections, peripheral nerve blocks, and pelvic floor physical therapy showed significant reductions in pain and improved function during work and intercourse in endometriosis patients who still had pain after excision surgery. The message here is that persistent pain after surgery does not necessarily mean the surgery failed. It may mean that pain processing itself needs treatment alongside the disease.

Hysterectomy as a Last Resort

For patients who have exhausted other surgical and medical options, hysterectomy remains an option, though it is not the guaranteed cure it is sometimes portrayed as. A population-based study found that the proportion of women experiencing any pain dropped by about 28% after hysterectomy, and severe pain dropped by 76%. The vast majority (84%) were satisfied with the result. Whether the ovaries were kept or removed did not significantly change pain outcomes or satisfaction in that study.

Younger patients face a more complicated picture. A study of women under 30 who underwent hysterectomy for endometriosis found that while similar proportions reported overall pain relief compared to older groups, they were more likely to report residual symptoms like pain during sex and urination. They also more frequently reported a psychological sense of loss and greater disruption to different aspects of their lives. Hysterectomy can be the right decision for the right patient, but the age at which it is performed and expectations going in both matter.

The Expectation Gap

One underappreciated factor in patient satisfaction after surgery is the gap between what people hope for and what the operation can realistically deliver. A qualitative study of pre-operative expectations found that patients placed a great deal of hope in laparoscopy, with positive expectations that may exceed the probable outcomes for some individuals. This is not the patients’ fault. After years of diagnostic delay and inadequate treatment, the prospect of definitive surgery carries enormous psychological weight. But it means that pre-operative counseling matters as much as the surgical skill itself. Patients who understand that complete, permanent pain relief is one possible outcome but not a guaranteed one tend to report higher satisfaction with the results they do get.

The Cost Dimension

Surgery for endometriosis carries a significant financial burden. A U.S. claims analysis found that patients in the surgery cohort had mean annual direct healthcare costs roughly three times higher than those managed without surgery (about $19,200 versus $6,400), with the surgery itself averaging about $7,300 as the single largest cost driver. Indirect costs, including lost work productivity, were also higher in the surgical group. These figures are worth keeping in mind alongside the clinical outcomes. The cost argument cuts both ways: surgery is expensive up front, but for patients whose disease is severe enough to impair work and daily function, the investment can pay for itself through reduced ongoing medical utilization and restored productivity. For patients with milder symptoms that respond well to hormonal management alone, the financial calculus tips the other direction.

Does Disease Stage Predict Outcomes

You might assume that stage I (minimal) endometriosis leads to better surgical results than stage IV (severe), but the evidence is surprisingly mixed. A study of over 700 women found that cumulative pregnancy rates at three years were remarkably similar across all four stages, ranging from 44% to 51% with no statistically significant difference. Pain recurrence showed a similar pattern: the cumulative probability of moderate or severe period-pain recurrence was actually slightly higher in stage I (32%) than in stage IV (19%), though the difference was not statistically significant. The researchers concluded that the standard staging system has inadequate predictive value for the clinical outcomes patients care about most. Disease relapse was the one area where stage mattered: stage IV disease had a relapse rate of 23% compared with only 3% for stage I. In practical terms, the stage of your endometriosis does not reliably predict how much your pain will improve or whether you will conceive, but more advanced disease does carry a higher risk of the disease physically reappearing.

Pelvic Floor Physical Therapy After Surgery

Pelvic floor physical therapy has gained visibility as both a stand-alone and post-operative treatment for endometriosis-related pain. The evidence, however, remains modest. A cross-sectional study found average patient-reported improvement scores indicating only minimal improvement in endometriosis pain symptoms with pelvic floor therapy, and roughly a third of patients reported their symptoms worsened or stayed the same regardless of whether therapy was done before or after surgery. On the other hand, when pelvic floor therapy was combined with nerve blocks and trigger point injections as part of a multimodal protocol, outcomes were more promising. Pelvic floor therapy is probably best understood not as a standalone fix but as one component in a broader post-operative recovery strategy, particularly for patients dealing with myofascial pain or pelvic floor dysfunction that developed during the years they lived with untreated disease.